Evidence-Based Prevention of Preeclampsia: Commonly Asked Questions in Clinical Practice

被引:15
|
作者
Wertaschnigg, Dagmar [1 ,2 ]
Reddy, Maya [1 ,3 ]
Mol, Ben W. J. [1 ,3 ]
Costa, Fabricio da Silva [1 ,4 ]
Rolnik, Daniel L. [1 ,3 ]
机构
[1] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia
[2] Paracelsus Med Univ, Dept Obstet & Gynecol, Salzburg, Austria
[3] Monash Hlth, Monash Womens, Clayton, Vic, Australia
[4] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Gynecol & Obstet, Ribeirao Preto, SP, Brazil
关键词
MOLECULAR-WEIGHT HEPARIN; LOW-DOSE ASPIRIN; HIGH-RISK; CALCIUM SUPPLEMENTATION; HYPERTENSIVE DISORDERS; GROWTH RESTRICTION; RANDOMIZED-TRIAL; WEEKS GESTATION; PREGNANT-WOMEN; VITAMINS C;
D O I
10.1155/2019/2675101
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
In this review, we discuss the recent literature regarding the prevention of preeclampsia and aim to answer common questions that arise in the routine antenatal care of pregnant women. Prescription of low-dose aspirin for high-risk patients has been shown to reduce the risk of preeclampsia (PE). A daily dose between 100 and 150 mg taken in the evening should be initiated prior to 16 weeks of gestation and can be continued until delivery. Calcium supplementation seems to be advantageous but currently it is only considered for patients with poor dietary intake and high risk for PE. Recent data about heparin are still conflicting, and therefore, heparin can currently not be recommended in the prevention of PE.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Evidence-Based Clinical Practice Guidelines: What is the Evidence?
    Luder, Anthony S.
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2011, 13 (11): : 689 - 691
  • [42] Molecular Allergy Diagnosis in Clinical Practice: Frequently Asked Questions
    不详
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2022, 32 (01) : 1 - 12
  • [43] Evidence-Based Practice Guideline Elder Abuse Prevention
    Daly, Jeanette M.
    Butcher, Howard K.
    [J]. JOURNAL OF GERONTOLOGICAL NURSING, 2018, 44 (07): : 21 - 30
  • [44] Athletic therapy and injury prevention: Evidence-based practice
    Raina, P
    Massfeller, H
    Macarthur, C
    [J]. ATHLETIC THERAPY TODAY, 2004, 9 (06): : 10 - 14
  • [45] EVIDENCE-BASED ASSESSMENT OF THE EFFECTIVENESS OF A CLINICAL PRACTICE GUIDELINE FOR PREVENTION OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURE
    Kajita, E.
    Nakatani, Y.
    Tamaki, J.
    Ito, N.
    Iki, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 101 - 101
  • [46] Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: Prevention
    Muscedere, John
    Dodek, Peter
    Keenan, Sean
    Fowler, Rob
    Cook, Deborah
    Heyland, Daren
    [J]. JOURNAL OF CRITICAL CARE, 2008, 23 (01) : 126 - 137
  • [47] Gaming Disorder: Evidence-based clinical practice
    Kuss, Daria J.
    Costa, Sebastiano
    [J]. JOURNAL OF BEHAVIORAL ADDICTIONS, 2019, 8 : 44 - 45
  • [48] Pharmacotherapy of osteoporosis:: Evidence-based clinical practice
    Fassbender, WJ
    Stumpf, UC
    Jockenhövel, F
    [J]. MEDIZINISCHE KLINIK, 2006, 101 : 173 - 177
  • [49] Evidence-based practice in clinical laboratory science
    Leibach, Elizabeth Kenimer
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2010, 40 (02): : 197 - 197
  • [50] Challenges to evidence-based prescribing in clinical practice
    Mamdani, Muhammad
    Ching, Andrew
    Golden, Brian
    Melo, Magda
    Menzefricke, Ulrich
    [J]. ANNALS OF PHARMACOTHERAPY, 2008, 42 (05) : 704 - 707